Oxcarbazepine For Suspension
Product Images NDC 33342-259

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 33342-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine-carton-label.jpg (Oxcarbazepine Carton Label)

Label for Oxcarbazepine Oral Suspension USP, 300 mg/5 mL, manufactured by Macleods Pharmaceuticals Limited. The label includes dosing instructions, storage conditions, and pharmacist dispensing guidance. The product is an oral suspension supplied in a 250 mL container and is for prescription use only.*

FDA Label Image

Oxcarbazepine-fig-1 (Oxcarbazepine Fig 1)

A Kaplan-Meier curve comparing time on trial from Day 2 to Day 11 for two treatment groups: oxcarbazepine and placebo. The y-axis represents the exit rate, ranging from 0.0 to 1.0, and the x-axis represents time in days. The graph includes a log-rank test p-value of 0.0001, indicating statistical comparison between the groups.*

FDA Label Image

Oxcarbazepine-fig-2 (Oxcarbazepine Fig 2)

A Kaplan-Meier survival curve graph comparing seizure rates over time between oxcarbazepine and placebo treatment groups. The x-axis represents days from the first dose to the first seizure, and the y-axis shows the seizure rate. The plot includes a log-rank test with a p-value of 0.046.*

FDA Label Image

Oxcarbazepine-fig-3 (Oxcarbazepine Fig 3)

A Kaplan-Meier plot showing exit rates over time in days for two treatment groups, HIGH and LOW. The y-axis represents the exit rate from 0 to 1, and the x-axis shows the time to exit in days up to 130. The graph includes a log-rank test p-value of 0.0001.*

FDA Label Image

Oxcarbazepine-fig-4 (Oxcarbazepine Fig 4)

A Kaplan-Meier survival curve graph showing time to exit (days) on the x-axis and exit rate on the y-axis. The graph compares two treatment groups labeled HIGH and LOW, with the HIGH group represented by a solid line and the LOW group by a dashed line. The plot includes a log-rank test p-value of 0.0001.*

FDA Label Image

Oxcarbazepine-image1 (Oxcarbazepine Image1)

An instructional illustration showing a plastic adapter and a medicine bottle with a child-resistant cap. The plastic adapter is designed to be pushed into the neck of the bottle on first use and should remain inside the bottle. The bottle contains 250 mL of medicine.*

FDA Label Image

Image 2 (Oxcarbazepine Image2)

An instructional illustration showing a 10 mL oral dosing syringe labeled with measurement marks from 1 mL to 10 mL. The syringe components are identified with arrows pointing to the barrel and plunger. The accompanying text explains the syringe fits into a plastic adapter to withdraw medicine from the bottle.*

FDA Label Image

Oxcarbazepine-image3 (Oxcarbazepine Image3)

Instructional diagram showing how to prepare the bottle of oxcarbazepine oral suspension. It depicts a hand shaking the bottle and provides steps to shake the bottle for at least 10 seconds, remove the child-resistant cap by pushing downward and turning counterclockwise, and a note to save the cap for resealing after use.*

FDA Label Image

Oxcarbazepine-image4 (Oxcarbazepine Image4)

An instructional illustration showing hands holding a bottle upright on a table, pushing a plastic adapter firmly into the neck of the bottle, accompanied by text instructions detailing how to install the adapter and replace the cap to ensure the adapter is fully inserted. The diagram is related to preparation for oral suspension dosage form use.*

FDA Label Image

Image 5 (Oxcarbazepine Image5)

An instructional illustration showing how to take oxcarbazepine oral suspension. It includes two line drawings: one of a hand shaking a bottle, and another of a syringe being pushed firmly into the bottle's plastic adapter. The text provides step-by-step directions to shake the bottle, open the child-resistant cap, ensure the syringe plunger is fully down, and insert the syringe into the bottle for dosing.*

FDA Label Image

Image 6 (Oxcarbazepine Image6)

Instructional diagrams showing how to use an oral syringe for dosing oxcarbazepine suspension, including holding and turning the bottle, filling the syringe, adjusting the plunger to the correct dose, removing the syringe, mixing medicine with water, and administering the dose to a patient.*

FDA Label Image

Oxcarbazepine-str (Oxcarbazepine Str)

Chemical structure diagram showing the molecular structure of oxcarbazepine, a prescription drug active ingredient. The diagram includes characteristic rings and functional groups that define the oxcarbazepine molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.